Tenax Therapeutics Inc (TENX)

StockNews.com Initiates Coverage on Tenax Therapeutics (NASDAQ:TENX) - Defense World

Defense World

Tenax Therapeutics (NASDAQ:TENX) Now Covered by Analysts at StockNews.com - Defense World

Defense World

Tenax Therapeutics Enhances Incentives and Adjusts Leadership Structure - TipRanks.com - TipRanks

TipRanks

Tenax Therapeutics, Inc. (NASDAQ:TENX) Short Interest Down 34.7% in May - Defense World

Defense World

Loss-Making Tenax Therapeutics, Inc. (NASDAQ:TENX) Expected To Breakeven In The Medium-Term - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Tenax Therapeutics, Inc. to Post Q2 2024 Earnings of ($1.72) Per Share, Zacks Small Cap Forecasts (NASDAQ:TENX) - Defense World

Defense World

TENX: First Quarter Results - Zacks Small Cap Research

Zacks Small Cap Research

TENX: First Quarter Results - Yahoo Finance

Yahoo Finance

TENX: First Quarter Results - Zacks Small Cap Research

Zacks Small Cap Research

Roth Capital Analysts Reduce Earnings Estimates for Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World

Defense World

Roth Capital Analysts Reduce Earnings Estimates for Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World

Defense World

Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewswire

GlobeNewswire

Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update - Yahoo Finance

Yahoo Finance

Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewswire

GlobeNewswire

Tenax Therapeutics, Inc. (NASDAQ:TENX) Short Interest Update - Defense World

Defense World

Tenax Therapeutics Inc expected to post a loss of $2.40 a share - Earnings Preview - XM

XM

Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with ... - Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with ... - GlobeNewswire

GlobeNewswire

Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Benzinga

Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Markets Insider

Markets Insider

Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”

GlobeNewswire Inc.

Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First ... - GlobeNewswire

GlobeNewswire

TENX Stock Earnings: Tenax Therapeutics Misses EPS for Q4 2023 - InvestorPlace

InvestorPlace

Tenax Therapeutics to Present at the 36th Annual Roth Conference - GlobeNewswire

GlobeNewswire

Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket

Benzinga

Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024 - GlobeNewswire

GlobeNewswire

Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan

GlobeNewswire Inc.

Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan - Yahoo Finance

Yahoo Finance

Tenax Therapeutics Raises $9M in Public Offering and Warrants - TipRanks.com - TipRanks

TipRanks

Tenax Therapeutics shares dives on $9M stock offering - The Business Journals

The Business Journals

Crude Oil Gains 3%; Kellanova Posts Upbeat Results

Benzinga

Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Dow Tumbles Over 100 Points; US Initial Jobless Claims Fall Last Week

Benzinga

US Stocks Mixed; Disney Earnings Top Views

Benzinga

Tenax Therapeutics prices 1.6M shares at $5.65 in public offering - TipRanks

TipRanks

Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering

GlobeNewswire Inc.

Why Disney Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

Benzinga

Why Is Tenax Therapeutics (TENX) Stock Down 64% Today? - InvestorPlace

InvestorPlace

Tenax Therapeutics Enrolls First Patient in Phase 3 LEVEL Study Evaluating TNX-103 (Oral Levosimendan) for the Treatment of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

GlobeNewswire Inc.

Why Fortinet Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

Benzinga

Tenax Therapeutics Enrolls First Patient in Phase 3 LEVEL Study Evaluating TNX-103 (Oral Levosimendan) for the ... - Yahoo Finance

Yahoo Finance

Nasdaq Down 50 Points; Willis Towers Watson Posts Upbeat Profit

Benzinga

Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Crude Oil Gains 1%; Centene Sales Top Views

Benzinga

Dow Jumps Over 100 Points; Eli Lilly Posts Upbeat Earnings

Benzinga

Tenax Therapeutics Announces USPTO Grants Notice of Allowance for U.S. Patent Application, Significantly ... - Yahoo Finance

Yahoo Finance

Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

TENX Stock Quote Price and Forecast - CNN

CNN

Breakeven On The Horizon For Tenax Therapeutics, Inc. (NASDAQ:TENX) - Yahoo Finance

Yahoo Finance

Tenax Therapeutics Announces Reverse Stock Split

GlobeNewswire Inc.